13 November 2019

Toxicology in Vitro

Toxicology in Vitro publishes original research papers and reviews on the application and use of in vitro systems for assessing or predicting the toxic effects of chemicals and elucidating their mechanisms of action. These in vitro techniques include utilizing cell or tissue cultures, isolated cells, tissue slices, subcellular fractions, transgenic cell cultures, and cells from transgenic organisms, as well as in silico modelling. The Journal focuses on investigations that involve the development and validation of new in vitro methods, e.g. for prediction of toxic effects based on traditional and in silico modelling; on the use of methods in high-throughput toxicology and pharmacology; elucidation of mechanisms of toxic action; the application of genomics, transcriptomics and proteomics in toxicology, as well as on comparative studies that characterize the relationship between in vitro and in vivo findings.
The Journal strongly encourages the submission of manuscripts that focus on the development of in vitro methods, their practical applications and regulatory use (e.g. in the areas of food components cosmetics, pharmaceuticals, pesticides, and industrial chemicals).

The Latest News from TIV (RSS feed):

                               

                               

                               

                               

                               

Related content

ESTIV Congress 2022

  • 0

Due to the COVID-19 pandemic and after thoughtful deliberation we have decided to postpone the congress to 2022 instead of the previously indicated dates in 2021. We kindly ask everyone to please save the new dates: 21-25 November 2022 . In the upcoming months, we will work on updating the website and determine a new list of important dates and deadlines for the congress. We look forward to gathering again in 2022 and in the meantime we wish everyone a healthy summer break!

ESTIV Early Career Award granted to Dr. Timothy Allen

  • 0

The European Society of Toxicology In Vitro (ESTIV) will grant an early career award for the first time in 2020 and intends to do so every 2 years coinciding with its biennial conferences…

ESTIV/ASCCT Webinars in 2020

Human biology-based approaches for COVID 19 therapeutics – that is the theme of the July 8 webinars presented by Malcolm Wilkinson and Samuel Constant…

Corporate Members

mattek in Vitro Life Science Laboratories

Gold Sponsor

Affiliated Societies

Invitrom Celltox IVTS

Memorandum of Understanding